Cargando…
Biomarkers Beyond the Natriuretic Peptides for Chronic Heart Failure: Galectin-3 and Soluble ST2
B-type natriuretic peptide (BNP) and NT-proBNP are widely used plasma biomarkers for the diagnosis of acute decompensated heart failure and prognosis for future cardiac disease. The clinical performance of these tests for management of chronic heart failure is somewhat limited by the markers’ high b...
Autor principal: | Wu, Alan H.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975258/ https://www.ncbi.nlm.nih.gov/pubmed/27683422 |
Ejemplares similares
-
Soluble ST2 in Heart Failure: A Clinical Role beyond B-Type Natriuretic Peptide
por: Riccardi, Mauro, et al.
Publicado: (2023) -
Comparative study of galectin-3 and B-type natriuretic peptide as biomarkers for the diagnosis of heart failure
por: Yin, Qiu-Sheng, et al.
Publicado: (2014) -
Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019) -
Role of galectin-3 and plasma B type-natriuretic peptide in predicting prognosis in discharged chronic heart failure patients
por: Feola, Mauro, et al.
Publicado: (2016) -
The Predictive Value of Plasma Brain Natriuretic Peptide and Galectin-3 in Elderly Patients Admitted for Heart Failure †
por: Testa, Marzia, et al.
Publicado: (2018)